Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate if adjunctive armodafinil treatment can
improve the cognitive deficits in patients with schizophrenia